Phytoestrogen product of red clover and pharmaceutical uses thereof
AssigneeSinoveda Canada, Inc.
InventorsYun Kau Tam, Yi-Chan James Lin, Brian Duff Sloley, Chih-Yuan Tseng
Life of this patent
Estimating the term…
Loading patent…
AssigneeSinoveda Canada, Inc.
InventorsYun Kau Tam, Yi-Chan James Lin, Brian Duff Sloley, Chih-Yuan Tseng
Estimating the term…
The present invention provides compositions comprising optimized ratios of Red clover phytoestrogens as determined by a proprietary physiologically based pharmacokinetic and pharmacodynamic model. The compositions are useful for modulating, preventing or treating postmenopausal or climacteric symptoms, which include but are not limited to bone loss, bone remodeling, hot flushes and vaginal atrophy. The present invention also provides methods for modulating, preventing or treating postmenopausal or climacteric symptoms using the compositions disclosed herein.
A method of modulating one or more climacteric symptoms in a subject, comprising the step of administering to the subject in need thereof an effective amount of a composition comprising Biochanin A, genistein, formononetin and daidzein, wherein the composition comprises 80%-96% Biochanin A, 1%-12% genistein, 1%-5% formononetin and 1%-5% of daidzein, wherein the effective amount includes 1.0-6.0 mg of total isoflavones, and the composition is administered via a route to avoid first-pass gastrointestinal and hepatic effects, and to avoid colonic bacterial metabolism, wherein the climacteric symptoms are selected from the group consisting of:
Dependencies are inferred from the claim text.